Pfizer Plaintiffs Defend Robbins Geller Fees In $400M Deal
Plaintiffs pushing for final approval of a $400 million settlement with Pfizer Inc. in an off-label marketing class action urged a New York federal judge on Friday to overrule objections to...To view the full article, register now.
Already a subscriber? Click here to view full article